NATERA, INC. Foreign Currency Transaction Gain (Loss), before Tax
NATERA, INC. (NTRA) reported Foreign Currency Transaction Gain (Loss), before Tax of -$258.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-05-08
- NATERA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$258.00K.
- NATERA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $32.00K.
- NATERA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$17.00K, a 180.95% decline year-over-year.
- NATERA, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-06-30 was $106.00K.
- NATERA, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was -$17.00K.
- NATERA, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$462.00K.
- NATERA, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$265.00K, a 13350.00% decline from fiscal 2022.
- NATERA, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $2.00K, a 81.82% decline from fiscal 2021.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$258.00K 10-Q · filed 2026-05-08 | -$226.00K derived: sum of 2 quarters · filed 2026-05-08 | -$243.00K derived: sum of 3 quarters · filed 2026-05-08 | -$137.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $15.00K derived: sum of 2 quarters · filed 2026-02-27 | $121.00K derived: sum of 3 quarters · filed 2026-02-27 | -$17.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $89.00K derived: sum of 2 quarters · filed 2025-11-07 | -$49.00K 10-Q · filed 2025-11-07 | -$155.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-06-30 | $106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$32.00K 10-Q · filed 2025-08-08 | -$138.00K derived: sum of 3 quarters · filed 2026-05-08 | -$117.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2025-03-31 | -$138.00K 10-Q · filed 2026-05-08 | -$244.00K derived: sum of 2 quarters · filed 2026-05-08 | -$223.00K derived: sum of 3 quarters · filed 2026-05-08 | -$241.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$106.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$85.00K derived: sum of 2 quarters · filed 2026-02-27 | -$103.00K derived: sum of 3 quarters · filed 2026-02-27 | -$462.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.00K derived: sum of 2 quarters · filed 2025-11-07 | -$356.00K 10-Q · filed 2025-11-07 | -$356.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$377.00K 10-Q · filed 2025-08-08 | -$377.00K derived: sum of 3 quarters · filed 2026-02-27 | -$377.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$359.00K 10-Q · filed 2025-05-09 | -$359.00K derived: sum of 2 quarters · filed 2026-02-27 | -$359.00K derived: sum of 3 quarters · filed 2026-02-27 | -$359.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | -$265.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | -$265.00K 10-Q · filed 2024-11-12 | -$275.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$265.00K 10-Q · filed 2024-08-09 | -$275.00K derived: sum of 3 quarters · filed 2025-02-28 | -$256.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$265.00K 10-Q · filed 2024-05-10 | -$275.00K derived: sum of 2 quarters · filed 2025-02-28 | -$256.00K derived: sum of 3 quarters · filed 2025-02-28 | -$544.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $9.00K derived: sum of 2 quarters · filed 2025-02-28 | -$279.00K derived: sum of 3 quarters · filed 2025-02-28 | $2.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$269.00K derived: sum of 2 quarters · filed 2023-11-09 | $12.00K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$288.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$7.00K 10-Q · filed 2023-08-04 | ||
| 2022-03-31 | $281.00K 10-Q · filed 2023-05-10 | |||
| 2021-12-31 | $11.00K 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |